Massachusetts Wealth Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
18,394
+190
| +1% | +$12.2K | 0.67% | 60 |
|
|
2025
Q1 | $1.15M | Sell |
18,204
-210
| -1% | -$13.3K | 0.79% | 52 |
|
|
2024
Q4 | $1.23M | Buy |
18,414
+230
| +1% | +$15.3K | 0.76% | 54 |
|
|
2024
Q3 | $1.27M | Buy |
18,184
+1,240
| +7% | +$86.6K | 0.8% | 54 |
|
|
2024
Q2 | $1.1M | Buy |
16,944
+2,245
| +15% | +$146K | 0.74% | 53 |
|
|
2024
Q1 | $951K | Buy |
14,699
+2,509
| +21% | +$162K | 0.67% | 60 |
|
|
2023
Q4 | $803K | Buy |
12,190
+3,200
| +36% | +$211K | 0.65% | 59 |
|
|
2023
Q3 | $513K | Sell |
8,990
-350
| -4% | -$20K | 0.47% | 66 |
|
|
2023
Q2 | $572K | Buy |
9,340
+675
| +8% | +$41.4K | 0.55% | 60 |
|
|
2023
Q1 | $544K | Sell |
8,665
-450
| -5% | -$28.2K | 0.56% | 59 |
|
|
2022
Q4 | $609K | Buy |
+9,115
| New | +$609K | 0.59% | 58 |
|